Modular Finance IR Consensus: XVIVO Perfusion – Consensus estimates Q1 2025
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
Number of contributors: 7 (all of which have been updated or confirmed before the report)
KPI (MSEK, unless otherwise specified) | Q1 2025E |
Net sales | 213 |
Organic growth in local currency (%) | 13.00 |
Gross profit | 159 |
EBITDA | 43.2 |
EBIT | 25.3 |
Net profit | 23.6 |
Earnings per share (SEK) | 0.75 |
XVIVO Perfusion’s Q1 report will be released on Thursday, 24 April 2025 at 07.30 CEST.